Amit Mandoli

5.0k total citations · 1 hit paper
19 papers, 607 citations indexed

About

Amit Mandoli is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Amit Mandoli has authored 19 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Organic Chemistry. Recurrent topics in Amit Mandoli's work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). Amit Mandoli is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). Amit Mandoli collaborates with scholars based in Netherlands, India and Italy. Amit Mandoli's co-authors include Ambika Chamoli, Santosh Kumar Behera, Kiran Kalia, Nawneet K. Kurrey, Joost H.A. Martens, Abhishek A. Singh, Hendrik G. Stunnenberg, Edo Vellenga, Lucia Altucci and Femke Simmer and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Amit Mandoli

19 papers receiving 606 citations

Hit Papers

Overview of oral cavity squamous cell carcinoma: Risk fac... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Mandoli Netherlands 10 363 135 123 103 76 19 607
Gulshan Sunavala‐Dossabhoy United States 14 288 0.8× 37 0.3× 65 0.5× 12 0.1× 44 0.6× 30 474
Katsunori Fukuda Japan 10 122 0.3× 69 0.5× 33 0.3× 16 0.2× 56 0.7× 27 354
Yuh‐Ling Chen Taiwan 15 610 1.7× 311 2.3× 118 1.0× 7 0.1× 14 0.2× 22 887
Sonali Rawat India 14 404 1.1× 142 1.1× 64 0.5× 8 0.1× 13 0.2× 22 632
Elisabeta Karl United States 8 224 0.6× 104 0.8× 173 1.4× 14 0.1× 8 0.1× 16 420
Emilios Gemenetzidis United Kingdom 11 460 1.3× 133 1.0× 251 2.0× 3 0.0× 18 0.2× 11 655
Chunming Huang China 9 302 0.8× 223 1.7× 83 0.7× 5 0.0× 9 0.1× 17 461
Eli Berg Norway 11 177 0.5× 208 1.5× 113 0.9× 78 0.8× 2 0.0× 17 434
Leah S. Royce United States 7 200 0.6× 121 0.9× 155 1.3× 13 0.1× 3 0.0× 7 519

Countries citing papers authored by Amit Mandoli

Since Specialization
Citations

This map shows the geographic impact of Amit Mandoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Mandoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Mandoli more than expected).

Fields of papers citing papers by Amit Mandoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Mandoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Mandoli. The network helps show where Amit Mandoli may publish in the future.

Co-authorship network of co-authors of Amit Mandoli

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Mandoli. A scholar is included among the top collaborators of Amit Mandoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Mandoli. Amit Mandoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chamoli, Ambika, et al.. (2025). Adamantane-Quinoxalone Hybrids: Precision Chemotypes and Their Molecular Mechanisms in Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 68(7). 7693–7706. 2 indexed citations
2.
Kumar, Hemant, et al.. (2024). Rare diseases and pyruvate kinase M2: a promising therapeutic connection. Drug Discovery Today. 29(5). 103949–103949. 2 indexed citations
3.
4.
Agarwal, Gopal, et al.. (2024). BM-MSC-Loaded Graphene-Collagen Cryogels Ameliorate Neuroinflammation in a Rat Spinal Cord Injury Model. ACS Applied Bio Materials. 7(3). 1478–1489. 11 indexed citations
5.
Mandoli, Amit, et al.. (2024). Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivatives. RSC Medicinal Chemistry. 15(8). 2729–2744. 2 indexed citations
6.
Jain, Alok, et al.. (2023). Discovery of fluorinated 2‑Styryl 4(3H)-quinazolinone as potential therapeutic hit for oral cancer. Bioorganic & Medicinal Chemistry. 81. 117193–117193. 6 indexed citations
7.
Chamoli, Ambika, et al.. (2022). A Series of Ferrocene-Containing Pyrazolo[1,5-a]pyrimidines Induce a Strong Antiproliferative Effect against Oral Cancer Cells. Organometallics. 41(16). 2365–2378. 15 indexed citations
8.
Rana, Dhwani, Sagar Salave, Anil B. Jindal, et al.. (2022). Bugs as Drugs: Understanding the Linkage between Gut Microbiota andCancer Treatment. Current Drug Targets. 23(9). 869–888. 4 indexed citations
9.
Chamoli, Ambika, et al.. (2021). Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncology. 121. 105451–105451. 291 indexed citations breakdown →
10.
Mandoli, Amit, Nicolas Cagnard, Guillaume Hypolite, et al.. (2020). CBFβ-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia. Cell Reports. 30(2). 299–307.e3. 7 indexed citations
12.
Yi, Guoqiang, Amit Mandoli, Esther Tijchon, et al.. (2019). CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1. Blood Cancer Journal. 9(3). 33–33. 7 indexed citations
13.
Gómez-Cuadrado, Laura, Milou Tenhagen, Adam Byron, et al.. (2018). E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer. Scientific Reports. 8(1). 15454–15454. 42 indexed citations
14.
Iacono, Giovanni, Aline Dubos, Hamid Méziane, et al.. (2018). Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome. Nucleic Acids Research. 46(10). 4950–4965. 31 indexed citations
15.
Liddo, Rosa Di, Silvia Barbon, Thomas Bertalot, et al.. (2016). Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells. International Journal of Nanomedicine. Volume 11. 5041–5055. 7 indexed citations
16.
Singh, Abhishek A., Amit Mandoli, Koen H.M. Prange, Marko Laakso, & Joost H.A. Martens. (2016). AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis. Oncotarget. 8(8). 12855–12865. 19 indexed citations
17.
Naidu, Vegi M., Franz Oswald, Medhanie Mulaw, et al.. (2016). MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML. Cell Reports. 16(2). 498–507. 29 indexed citations
18.
Kuznetsova, Tatyana, Shuang-Yin Wang, Nagesha Rao, et al.. (2015). Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization. Genome biology. 16(1). 264–264. 36 indexed citations
19.
Martens, Joost H.A., Amit Mandoli, Femke Simmer, et al.. (2012). ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. Blood. 120(19). 4038–4048. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026